Loading…
Saint-Gaudens National Historical Park Redesignation Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
98pct
520d open
vs 7,393 other HR bills in the 115th — cohort avg 50d
(This measure has not been amended since it was reported to the House on August 25, 2017. The summary of that version is repeated here.) Saint-Gaudens National Historical Park Redesignation Act (Sec. 2) This bill redesignates the Saint-Gaudens National Historic Site, in New Hampshire, as the "Saint-Gaudens National Historical Park."
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (3)
2019 · fourth_quarter · Health Issues
- H.R. 965/ S. 340, Creating and Restoring Equal Access To Equivalent Samples Act of 2017 (CREATES Act), support passage. - H.R. 985, Fair Access for Safe and Timely Generics Act of 2017 (FAST Generics Act), support passage. -H.R. 2035/S. 995, Lifespan Respite Care Reauthorization Act, support reauthorization - H.R. 3208/ S.1755 - Real Emergency Access for Aging and Disability Inclusion for Disasters Act, support passage - H.R. 3215/ S. 1754 - Disaster Relief Medicaid Act, support passage - S.2400/ H.R. 4322 - Expanding Cannabis Research and Information Act, support passage - H.R. 3439 - Reauthorization of the Patient Centered Outcomes Research Institute, support reauthorization. -H.R. 2781 - Empower for Health Act of 2019, support passage -H.R. 2035, Lifespan Respite Care Reauthorization Act of 2019, support passage -H.R. 2296/S.1391 - FAIR Drug Pricing Act of 2019, support passage - H.R. 3630 - No Surprises Act, support passage -H.R. 1010, To provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect, support passage. -H.R. 986, The Protecting Americans with Preexisting Conditions Act of 2019, support passage. -H.R.1386, Expand Navigators Resources for Outreach, Learning, and Longevity (ENROLL) Act of 2019, support passage. -H.R. 2293, the Protecting Access to Wheelchairs Act, support passage. -H.R. 2408, the Ensuring Access to Quality Complex Rehabilitation technology Act, support passage. -H.R 3 - Lower Drug Costs Now Act of 2019, support passage - H.R. 2387, the Stop The Overuse of Petitions and Get Affordable Medicines to Enter Soon (STOP GAMES) Act of 2019, support passage - H.R. 3107, Improving Seniors Timely Access to Care Act of 2019, support passage -S. 1935, Family Coverage Act, support passage. -S.1556, No Junk Plans Act, support passage. -S. 1223, the Protecting Beneficiary Access to Complex Rehab Technology Act, support passage - S.475, Reducing Existing Costs Associated with Pharmaceuticals for Seniors Act of 2019 (RX Cap Act), support passage - S. 637, Combatting Unreasonable Rises and Excessively High Drug Prices Act (CURE High Drug Prices Act), support passage - S.366, Forcing Limits on Abusive and Tumultuous Prices (FLAT Prices) Act, support passage -S. 63, Preserve Access to Affordable Generics and Biosimilars Act, support passage -S. 659, Biologic Patent Transparency Act, support passage -S.1895 - Lower Health Care Costs Act, support passage - S. 1280/HR 2477 - Beneficiary Enrollment Notification and Eligibility Simplification (BENES) Act, support passage - S. 691 - Medicare Extra Rx Help Act- support passage - S. 2543 - Prescription Drug Price Reduction Act of 2019 - support passage - Menendez - Lankford- Cardin-Daines Amendment 1 Incentivizing Generic and Biosimilar Use in Medicare Part D - support adoption -Menendez -Lankford - Cardin --Daines Amendment 2 Incentivizing Generic Use in Medicare Part D - support adoption -S, 1801, Low Cost Generics Act of 2019, support passage -S.2911, the Seniors Prescription Drug Relief Act of 2019, support passage.
Placed on Senate Legislative Calendar under General Orders. Calendar No. 512.
Committee on Energy and Natural Resources. Reported by Senator Murkowski without amendment. With written report No. 115-299.
Committee on Energy and Natural Resources. Ordered to be reported without amendment favorably.
Received in the Senate and Read twice and referred to the Committee on Energy and Natural Resources.
Motion to reconsider laid on the table Agreed to without objection.
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 401 - 0 (Roll no. 545). (text: CR H7642)
HousePassed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 401 - 0 (Roll no. 545).(text: CR H7642)
HouseConsidered as unfinished business. (consideration: CR H7651)
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $83,990 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · fourth_quarter · Health Issues
- H.R. 965/ S. 340, Creating and Restoring Equal Access To Equivalent Samples Act of 2017 (CREATES Act), support passage. - H.R. 985, Fair Access for Safe and Timely Generics Act of 2017 (FAST Generics Act), support passage. -H.R. 2035/S. 995, Lifespan Respite Care Reauthorization Act, support reauthorization - H.R. 3208/ S.1755 - Real Emergency Access for Aging and Disability Inclusion for Disasters Act, support passage - H.R. 3215/ S. 1754 - Disaster Relief Medicaid Act, support passage - S.2400/ H.R. 4322 - Expanding Cannabis Research and Information Act, support passage - H.R. 3439 - Reauthorization of the Patient Centered Outcomes Research Institute, support reauthorization. -H.R. 2781 - Empower for Health Act of 2019, support passage -H.R. 2035, Lifespan Respite Care Reauthorization Act of 2019, support passage -H.R. 2296/S.1391 - FAIR Drug Pricing Act of 2019, support passage - H.R. 3630 - No Surprises Act, support passage -H.R. 1010, To provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect, support passage. -H.R. 986, The Protecting Americans with Preexisting Conditions Act of 2019, support passage. -H.R.1386, Expand Navigators Resources for Outreach, Learning, and Longevity (ENROLL) Act of 2019, support passage. -H.R. 2293, the Protecting Access to Wheelchairs Act, support passage. -H.R. 2408, the Ensuring Access to Quality Complex Rehabilitation technology Act, support passage. -H.R 3 - Lower Drug Costs Now Act of 2019, support passage - H.R. 2387, the Stop The Overuse of Petitions and Get Affordable Medicines to Enter Soon (STOP GAMES) Act of 2019, support passage - H.R. 3107, Improving Seniors Timely Access to Care Act of 2019, support passage -S. 1935, Family Coverage Act, support passage. -S.1556, No Junk Plans Act, support passage. -S. 1223, the Protecting Beneficiary Access to Complex Rehab Technology Act, support passage - S.475, Reducing Existing Costs Associated with Pharmaceuticals for Seniors Act of 2019 (RX Cap Act), support passage - S. 637, Combatting Unreasonable Rises and Excessively High Drug Prices Act (CURE High Drug Prices Act), support passage - S.366, Forcing Limits on Abusive and Tumultuous Prices (FLAT Prices) Act, support passage -S. 63, Preserve Access to Affordable Generics and Biosimilars Act, support passage -S. 659, Biologic Patent Transparency Act, support passage -S.1895 - Lower Health Care Costs Act, support passage - S. 1280/HR 2477 - Beneficiary Enrollment Notification and Eligibility Simplification (BENES) Act, support passage - S. 691 - Medicare Extra Rx Help Act- support passage - S. 2543 - Prescription Drug Price Reduction Act of 2019 - support passage - Menendez - Lankford- Cardin-Daines Amendment 1 Incentivizing Generic and Biosimilar Use in Medicare Part D - support adoption -Menendez -Lankford - Cardin --Daines Amendment 2 Incentivizing Generic Use in Medicare Part D - support adoption -S, 1801, Low Cost Generics Act of 2019, support passage -S.2911, the Seniors Prescription Drug Relief Act of 2019, support passage.
Client expense: $83,990 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · third_quarter · Health Issues
- H.R. 965/ S. 340, Creating and Restoring Equal Access To Equivalent Samples Act of 2017 (CREATES Act), support passage. - H.R. 985, Fair Access for Safe and Timely Generics Act of 2017 (FAST Generics Act), support passage. -H.R. 2035/S. 995, Lifespan Respite Care Reauthorization Act, support reauthorization - H.R. 3208/ S.1755 - Real Emergency Access for Aging and Disability Inclusion for Disasters Act, support passage - H.R. 3215/ S. 1754 - Disaster Relief Medicaid Act, support passage - S.2400/ H.R. 4322 - Expanding Cannabis Research and Information Act, support passage - H.R. 3439 - Reauthorization of the Patient Centered Outcomes Research Institute, support reauthorization. -H.R. 2781 - Empower for Health Act of 2019, support passage -H.R. 2035, Lifespan Respite Care Reauthorization Act of 2019, support passage -H.R. 2296/S.1391 - FAIR Drug Pricing Act of 2019, support passage - H.R. 3630 - No Surprises Act, support passage -H.R. 1010, To provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect, support passage. -H.R. 986, The Protecting Americans with Preexisting Conditions Act of 2019, support passage. -H.R.1386, Expand Navigators Resources for Outreach, Learning, and Longevity (ENROLL) Act of 2019, support passage. -H.R. 2293, the Protecting Access to Wheelchairs Act, support passage. -H.R. 2408, the Ensuring Access to Quality Complex Rehabilitation Technology Act, support passage. -H.R 3 - Lower Drug Costs Now Act of 2019, support passage -S. 1935, Family Coverage Act, support passage. -S.1556, No Junk Plans Act, support passage. -S. 1223, the Protecting Beneficiary Access to Complex Rehab Technology Act, support passage - S.475, Reducing Existing Costs Associated with Pharmaceuticals for Seniors Act of 2019 (RX Cap Act), support passage - S. 637, Combatting Unreasonable Rises and Excessively High Drug Prices Act (CURE High Drug Prices Act), support passage - S.366, Forcing Limits on Abusive and Tumultuous Prices (FLAT Prices) Act, support passage -S. 63, Preserve Access to Affordable Generics and Biosimilars Act, support passage -S. 659, Biologic Patent Transparency Act, support passage -S.1895 - Lower Health Care Costs Act, support passage - S. 1280/HR 2477 - Beneficiary Enrollment Notification and Eligibility Simplification (BENES) Act, support passage - S. 691 - Medicare Extra Rx Help Act- support passage - S. 2543 - Prescription Drug Price Reduction Act of 2019 - support passage - Menendez - Lankford- Cardin-Daines Amendment 1 Incentivizing Generic and Biosimilar Use in Medicare Part D - support adoption -Menendez -Lankford - Cardin --Daines Amendment 2 Incentivizing Generic Use in Medicare Part D - support adoption
Client expense: $91,539 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · second_quarter · Health Issues
- H.R. 965/ S. 340, Creating and Restoring Equal Access To Equivalent Samples Act of 2017 (CREATES Act), support passage. - H.R. 985, Fair Access for Safe and Timely Generics Act of 2017 (FAST Generics Act), support passage. -H.R. 2035/S. 995, Lifespan Respite Care Reauthorization Act, support reauthorization of the Lifespan Respite Care Program. - H.R. 3208/ S.1755 - Real Emergency Access for Aging and Disability Inclusion for Disasters Act, support passage - H.R. 3215/ S. 1754 - Disaster Relief Medicaid Act, support passage - H.R. 3439 - Reauthorization of the Patient Centered Outcomes Research Institute, support reauthorization. -H.R. 2781 - Empower for Health Act of 2019, support passage -H.R. 2035, Lifespan Respite Care Reauthorization Act of 2019, support passage -H.R. 2296/S.1391 - FAIR Drug Pricing Act of 2019, support passage - H.R. 3630 - No Surprises Act, support passage -H.R. 1010, To provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect, support passage. -H.R. 986, The Protecting Americans with Preexisting Conditions Act of 2019, support passage. -H.R.1386, Expand Navigators Resources for Outreach, Learning, and Longevity (ENROLL) Act of 2019, support passage. -H.R. 2293, the Protecting Access to Wheelchairs Act, support passage. H.R. 2408, the Ensuring Access to Quality Complex Rehabilitation Technology Act, support passage. -S. 1935, Family Coverage Act, support passage. -S.1556, No Junk Plans Act, support passage. -S. 1223, the Protecting Beneficiary Access to Complex Rehab Technology Act, support passage - S.475, Reducing Existing Costs Associated with Pharmaceuticals for Seniors Act of 2019 (RX Cap Act), support passage - S. 637, Combatting Unreasonable Rises and Excessively High Drug Prices Act (CURE High Drug Prices Act), support passage - S.366, Forcing Limits on Abusive and Tumultuous Prices (FLAT Prices) Act, support passage -S. 63, Preserve Access to Affordable Generics and Biosimilars Act, support passage -S. 659, Biologic Patent Transparency Act, support passage -S.1895 - Lower Health Care Costs Act, support passage - S. 1280 - Beneficiary Enrollment Notification and Eligibility Simplification (BENES) Act, support passage - S. 691 - Medicare Extra Rx Help Act- support passage
Client expense: $78,144 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · second_quarter · Pharmacy
S.340/HR 965, the Creating and Restoring Equal Access to Equivalent Samples Act of 2017, provisions relating to the provision of brand drug products by brand manufacturers to generic manufacturers for development testing, and for shared Risk Evaluation and Mitigation (REMS) programs for brand and generic pharmaceuticals; H.R. 1506, the Fair And Immediate Release of Generic Drugs Act, provisions relating to pharmaceutical market blockages caused by "parked" Hatch-Waxman 180 day exclusivity periods; HR 938, the Bringing Low-cost Options and Competition While Keeping Incentives for New Generics Act, provisions relating to the Hatch-Waxman Acts 180-day exclusivity framework; HR 987, Strengthening Health Care and Lowering Prescription Drug Costs, Title I, Subtitle A, Section 101, provisions relating to the Hatch-Waxman Acts 180-day exclusivity framework; S. 1895-Lower Health Care Costs Act Section 205, Preventing Blocking of Generic Drugs, provisions relating to the Hatch-Waxman Acts 180-day exclusivity framework; Federal policy relating to pharmaceutical market blockages caused by parked Hatch-Waxman 180-day exclusivity periods; and HR 1499, the Protecting Consumer Access to Generic Drugs Act of 2019, provisions relating to patent settlements between brand and generic drug companies.
Client expense: $150,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · first_quarter · Pharmacy
S. 340/HR965, the Creating and Restoring Equal Access to Equivalent Samples Act of 2017, provisions relating to the provision of brand drug products by brand manufacturers to generic manufacturers for development testing, and for shared Risk Evaluation and Mitigation (REMS) programs for brand and generic pharmaceuticals; HR 938, the Bringing Low-cost Options and Competition While Keeping Incentives for New Generics Act, provisions relating to the Hatch-Waxman Acts 180-day exclusivity framework; Federal policy relating to pharmaceutical market blockages caused by parked Hatch-Waxman 180-day exclusivity periods; HR 1520, the Purple Book Continuity Act of 2019, provisions relating to publication of patents for biological products in the FDA Purple Book; HR 1503, the Orange Book Transparency Act of 2019, provisions relating to ensuring the FDAs Orange Book is accurate and up to date; HR 1499, the Protecting Consumer Access to Generic Drugs Act of 2019, provisions relating to patent settlements between brand and generic drug companies; Federal policy relating to generic pharmaceutical drug prices; and Implementation of Public Law 115-52, the FDA Reauthorization Act of 2017, Section 808, Incentivizing Generic Drug Developments, provisions relating to exclusivity for competitive generic therapies.
Client expense: $180,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · first_quarter · Health Issues
- H.R. 965/ S. 340, Creating and Restoring Equal Access To Equivalent Samples Act of 2017 (CREATES Act), support passage. - H.R. 985, Fair Access for Safe and Timely Generics Act of 2017 (FAST Generics Act), support passage. -H.R. 2035/S. 995, Lifespan Respite Care Reauthorization Act, support reauthorization of the Lifespan Respite Care Program. - S.475, Reducing Existing Costs Associated with Pharmaceuticals for Seniors Act of 2019 (RX Cap Act), support passage - S. 637, Combatting Unreasonable Rises and Excessively High Drug Prices Act (CURE High Drug Prices Act), support passage - S.366, Forcing Limits on Abusive and Tumultuous Prices (FLAT Prices) Act, support passage -S. 63, Preserve Access to Affordable Generics and Biosimilars Act, support passage -S. 659, Biologic Patent Transparency Act, support passage - No bill number yet - Reauthorization of the Patient Centered Outcomes Research Institute, support reauthorization.
Client expense: $108,346 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2018 · second_quarter · Real Estate/Land Use/Conservation
H.R.360 - Greater Grand Canyon Heritage National Monument Act H.R.502 - To permanently reauthorize the Land and Water Conservation Fund. H.R.538 - Ocmulgee Mounds National Historical Park Boundary Revision Act H.R.965 - Saint-Gaudens National Historical Park Redesignation Act H.R.1002 - National Heritage Area Act of 2017 H.R.1026 - North Country National Scenic Trail Route Adjustment Act H.R.1791 - Mountains to Sound Greenway National Heritage Act H.R.2415 - Everglades FIRST Act H.R.2897 -To authorize the Mayor of the District of Columbia and the Director of the National Park Service to enter into cooperative management agreements for the operation, maintenance, and management of units of the National Park System in the District of Columbia, and for other purposes. H.R.2991 - Susquehanna National Heritage Area Act H.R.3400 - Recreation Not Red-Tape Act H.R.3990 - National Monument Creation and Protection Act H.R.4086 - Rim of the Valley Corridor Preservation Act H.R.4644 - Yellowstone Gateway Protection Act H.R.4760 - Securing America's Future Act of 2018 H.R.4895 - Medgar Evers Home National Monument Act H.R.5148 - Protect Public Use of Public Lands Act H.R.5149 - Unlocking Public Lands Act H.R.5210 - National Park Restoration Act H.R.5655 - Camp Nelson Heritage National Monument Act H.R.5751 - Golden Spike 150th Anniversary Act H.R.6136 - Border Security and Immigration Reform Act of 2018 S.33 - Improved National Monument Designation Process Act S.135 - Ocmulgee Mounds National Historical Park Boundary Revision Act S.363 - North Country National Scenic Trail Route Adjustment Act S.392 - 400 Years of African-American History Commission Act S.502 - A bill to modify the boundary of Voyageurs National Park in the State of Minnesota, and for other purposes. S.569 - Land and Water Conservation Authorization and Funding Act S.896 - A bill to permanently reauthorize the Land and Water Conservation Fund S.1430 - Chesapeake Bay Gateways and Watertrails Network Reauthorization Act S.1645 - Thurgood Marshall's Elementary School Study Act S.1646 - President Street Station Study Act S.2102 - Acadia National Park Boundary Clarification Act S.2354 - ANTIQUITIES Act of 2018 S.2509 - National Park Restoration Act S.2797 - White Sands National Park Establishment Act
2017 · third_quarter · Real Estate/Land Use/Conservation
H.R.763 - Acadia National Park Boundary Clarification Act H.R.965 - Saint-Gaudens National Historical Park Redesignation Act H.R.1002 - National Heritage Area Act of 2017 H.R.1488 - Indiana Dunes National Park Act H.R.1489 - MAST Act H.R.2816 - Great Smoky Mountains National Park Agreement Act of 2017 H.R.2897 - To authorize the Mayor of the District of Columbia and the Director of the National Park Service to enter into cooperative management agreements for the operation, maintenance, and management of units of the National Park System in the District of Columbia, and for other purposes. H.R.2936 - Resilient Federal Forests Act of 2017 H.R.3063 - Chesapeake Bay Gateways and Watertrails Network Reauthorization Act of 2017 H.R.3115 - Superior National Forest Land Exchange Act of 2017 H.R.3565 - Federal Land Freedom Act S.32 - California Desert Protection and Recreation Act of 2017 S.33 - Improved National Monument Designation Process Act S.257 - Acadia National Park Boundary Clarification Act S.312 - Saint-Gaudens National Historical Park Redesignation Act S.391 - African Burial Ground International Memorial Museum and Educational Center Act S.1073 - Escambia County Land Conveyance Act S.1430 - Chesapeake Bay Gateways and Watertrails Network Reauthorization Act S.1438 - Gateway Arch National Park Designation Act S.1644 - Captain John Smith Chesapeake National Historic Trail Parity Act
Client expense: $140,539 · Firm income: Not reported
DEBATE - The House proceeded with forty minutes of debate on H.R. 965.
Considered under suspension of the rules. (consideration: CR H7642-7643)
Mr. Thompson (PA) moved to suspend the rules and pass the bill, as amended.
Placed on the Union Calendar, Calendar No. 197.
Reported (Amended) by the Committee on Natural Resources. H. Rept. 115-277.
Congress.gov source codes: 5000, H12200
Ordered to be Reported (Amended) by Unanimous Consent.
Committee Consideration and Mark-up Session Held.
Referred to the Subcommittee on Federal Lands.
Referred to the House Committee on Natural Resources.
Introduced in House
Congress.gov source codes: 1000, Intro-H
| House |
| Reported by |
| August 25, 2017 |
| Natural Resources Committee | House | Markup by | July 26, 2017 |
| Natural Resources Committee | House | Referred to | February 7, 2017 |
| August 25, 2017 |
| Introduced in House | February 7, 2017 |
Client expense: $172,488 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), SENATE
Government targets: HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), SENATE